SIRT1 and colorectal carcinoma: It activates the Wnt/β-catenin signaling pathway, and inhibits miR-34a/SIRT1 feedback loop, which in turn promotes CRC progression, invasion, and metastasis, etc. The above studies show that NEAT1 can be used as a diagnostic marker and is a potential therapeutic target for CRC.